Central Pennsylvania Breast Cancer Consortium:
Spring 2026 Update

D7127

+ Add to Google Calendar + Add to Outlook

This presentation is designed to provide participants with an overview of current breast cancer research and therapies.

The target audience includes physicians, advanced practice providers, nurses and other health care professionals who are actively involved in breast cancer care.

• Review the new treatment options for triple negative breast cancer.
• Discuss outcomes with antibody drug conjugates against human epidermal growth factor receptor 2 (HER2) in different stages of HER2-positive (HER2+) breast cancer.
• Discuss the use of liquid biopsy in predicting outcomes in Her 2 + breast cancer.
• Review the role of new estrogen receptor degraders or downregulators (SERD) in early and advanced HR + breast cancer.

• 5:15 p.m. | Check-in, Hors d’oeuvres, Networking, and Visit Exhibitors
• 6:15 p.m. | Dinner Buffet
• 6:45 p.m. | Welcome Remarks and Presentations
• 8:30 p.m. | Adjournment

Karen Muindi, MD, PhD
PGY-5 Fellow, Hematology/Oncology Fellowship
Department of Medicine, Division of Hematology/Oncology
Penn State College of Medicine

Hyma Polimera, MD
Associate Professor, Department of Medicine
Division of Hospital Medicine
Penn State College of Medicine

Cristina Truica, MD
Associate Professor, Department of Medicine
Director of Breast Medical Oncology, Division of Hematology and Oncology
Cancer Institute, Next-Generation Therapies
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Penn State College of Medicine
Penn State Cancer Institute

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no fee for healthcare professionals, but registration is required. Registration includes the cost of instruction, online handout materials and all listed meals.

Medical Science Liasons $150. Medical Science Liasons at Penn State educational activities are expected to abide by the ACCME’s Standards of Commercial Support. Promotional materials cannot be displayed or distributed in the lecture rooms immediately before, during or after CME activities. MSL registrations are limited.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Monday, April 13, will incur a $25 late fee.

Cancellations received after Tuesday, April 7, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Wednesday, April 8.

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7127